Chenhai Capital
Overview
Chenhai Capital is a growth equity and venture capital firm headquartered in Shanghai, China, focused on early-stage and growth-stage investments in technology and culture sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Hangzhou Weinian Brand Management Co., Ltd. | Oct 2020 | Series C | Co-investor |
| Evopoint Biosciences | Feb 2024 | Series E | Co-investor |
| Renren Video | Dec 2017 | Series B Extension | Lead |
| Hangzhou Taofenba Network Technology Co., Ltd. | Oct 2015 | Series B | Lead |
| Well-Link Tech | Apr 2021 | Series A | Co-investor |
Key People
Chen Chen
Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Chenhai Capital based?
Chenhai Capital is headquartered in Shanghai, China.
When was Chenhai Capital founded?
Chenhai Capital was founded in 2015.
How many portfolio companies does Chenhai Capital have?
Chenhai Capital has 5 portfolio companies in Caplight's dataset.
What are some companies in Chenhai Capital's portfolio?
Portfolio companies visible on Caplight include Hangzhou Weinian Brand Management Co., Ltd., Evopoint Biosciences, Renren Video, Hangzhou Taofenba Network Technology Co., Ltd., Well-Link Tech.
What was Chenhai Capital's most recent investment shown here?
Chenhai Capital's most recent investment in this portfolio sample was in Evopoint Biosciences in 2024.
What sectors does Chenhai Capital focus on?
Chenhai Capital focuses on Consumer & Commerce, Healthcare & Life Sciences, Media, Entertainment & Gaming, Consumer & Commerce, AI, Data & Cloud Infrastructure, Media, Entertainment & Gaming, Media, Entertainment & Gaming.
What company stages does Chenhai Capital focus on?
Chenhai Capital typically invests at the MultiStage stage.